Rare diseases
Investigational molecules
Locations
Back to Slovakia231 clinical trials in Kosice, Slovakia across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis
SlovakiaComparing weekly insulin icodec and daily insulin glargine with insulin aspart in adults with type 1 diabetes: a 26-week study of blood sugar control
SlovakiaLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
SlovakiaStudy of lutikizumab and ravagalimab in adults with moderate to severe rheumatoid arthritis
SlovakiaComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
SlovakiaStudy Comparing EYP-1901 and Aflibercept for Patients with Wet Age-Related Macular Degeneration
SlovakiaStudy on the Safety and Effectiveness of AZD8630 for Adults with Uncontrolled Asthma at Risk of Exacerbations
SlovakiaStudy of PF-06821497 with Enzalutamide for Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with Abiraterone Acetate
SlovakiaStudy of atropine sulfate eye drops (0.
SlovakiaStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
SlovakiaStudy of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment
SlovakiaStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on chronic respiratory conditions, including studies evaluating new treatments for COPD and uncontrolled asthma. Trials are examining novel therapeutic approaches to improve patient outcomes and quality of life.
Research includes evaluation of medications like tezepelumab for COPD and AZD8630 for asthma control.
Comprehensive studies addressing cardiovascular health and metabolic conditions, from heart failure prevention to lipid disorders management.
Current trials are exploring innovative combinations of medications for cardiovascular risk reduction and metabolic control.
Advanced research into inflammatory and autoimmune disorders, including studies on Crohn's disease, ulcerative colitis, and Sjögren's syndrome.
Trials are evaluating novel biological treatments and targeted therapies for various autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
